Article Details

SpringWorks price target raised at Goldman Sachs after trial win for lead assets - Seeking Alpha

Retrieved on: 2022-05-24 16:11:13

Tags for this article:

Click the tags to see associated articles and topics

SpringWorks price target raised at Goldman Sachs after trial win for lead assets - Seeking Alpha. View article details on HISWAI: https://seekingalpha.com/news/3842302-swtx-stock-lower-even-as-goldman-raises-price-target-after-trial-win

Excerpt

Goldman Sachs has increased the price target on SpringWorks Therapeutics (SWTX) on Tuesday after the clinical-stage biotech reported positive data ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up